Pfizer announces positive topline results from Phase 3 study of hemophilia A gene therapy candidate
Giroctocogene fitelparvovec study meets primary and key secondary objectives of superiority compared to prophylaxis
Giroctocogene fitelparvovec study meets primary and key secondary objectives of superiority compared to prophylaxis
This strategic move aims to make Cupid's high-quality products more accessible to consumers nationwide
Shilpa Biologicals has developed high concentration adalimumab (100 mg/mL)
Phase III ARANOTE trial met primary endpoint, significantly increasing radiological progression-free survival (rPFS) with NUBEQA plus androgen deprivation therapy (ADT) compared to placebo plus ADT
The innovative ‘Street Safe’ Rapid Testing Kit should be provided to all vendors attending the Food Safety and Certification (FoSTaC) trainings to ensure that safe food is used by the street food vendors across the country
Susvimo is a unique therapeutic approach that provides continuous delivery of medicine to the eye through a refillable implant
Findings from the SEIMC-GeSIDA Foundation (FSG) PASO-DOBLE study will include treatment efficacy, safety, and weight gain
Utidelone can penetrate BBB due to its unique physicochemical characteristics and insusceptibility to P-glycoprotein-mediated efflux
India boasts the largest livestock population, with 536 million livestock and 851 million poultry
Submission based on positive SUPERNOVA Phase III trial data which demonstrated a statistically significant reduction in the incidence of COVID?19 in an immunocompromised patient population
Subscribe To Our Newsletter & Stay Updated